What are the indications for coronary artery calcium (CAC) scanning?

Indications for Coronary Artery Calcium (CAC) Scoring

CAC scoring is primarily indicated for asymptomatic adults aged ≥40 years with intermediate (7.5%-20%) or borderline (5%-7.5%) 10-year ASCVD risk when the decision to initiate statin therapy remains uncertain. 1

Primary Indications by Risk Category

Intermediate Risk (7.5%-20% 10-year ASCVD risk)

• Age ≥40 years, asymptomatic, no known CAD
• Treatment decision unclear after traditional risk assessment
• This represents the strongest and most consistent indication across all major guidelines 1

Borderline Risk (5%-7.5% 10-year ASCVD risk)

• When risk-enhancing factors are present and treatment decision remains uncertain 1
• Risk-enhancing factors include:
  • Family history of premature ASCVD
  • Persistently elevated LDL-C ≥160 mg/dL or triglycerides ≥175 mg/dL
  • Chronic kidney disease
  • Metabolic syndrome
  • Inflammatory conditions (rheumatoid arthritis, psoriasis, HIV)
  • South Asian ethnicity
  • Women-specific factors (preeclampsia, premature menopause)

Low Risk (<5% 10-year ASCVD risk)

• Strong family history of premature ASCVD 1
• Multiple cardiovascular risk factors despite low calculated risk
• Age ≥40 years with specific concerns warranting risk refinement

Special Populations

Diabetes Mellitus

• Young patients with diabetes (Type 1 DM <35 years, Type 2 DM <50 years) with disease duration <10 years and no other risk factors 1
• Diabetic patients age 40-60 years when treatment intensity is uncertain 1

High-Risk Patients Reluctant to Accept Treatment

• CAC = 0 can justify withholding statin therapy in patients calculated to be high risk but hesitant about treatment 1
• Provides objective evidence to guide shared decision-making

Younger Adults (Age 30-49 years)

• Presence of multiple risk factors (smoking, hyperglycemia, hyperlipidemia, hypertension) 2
• Strong family history of premature CAD
• Note: Over 34% of young adults have CAC >0, and 7.2% have CAC >100 with 10-fold higher mortality 2

Key Exclusions (When CAC is NOT Indicated)

Do not order CAC in:

• Patients with known clinical ASCVD or established CAD 1
• Symptomatic patients (chest pain, dyspnea) - these require functional or anatomic testing, not CAC
• Very low risk (<5%) without risk-enhancing factors
• Very high risk (≥20%) already warranting statin therapy 2
• Patients already on appropriate preventive therapy with good adherence

Treatment Thresholds Based on CAC Results

Once CAC is obtained, management follows these evidence-based thresholds 1:

• CAC = 0: Downgrade risk, withhold statin (unless diabetes, family history of premature CHD, or active smoking present)
• CAC = 1-99: Favors statin therapy, especially age >55 years
• CAC ≥100 or ≥75th percentile: Initiate statin therapy
• CAC ≥300-400: Consider high-intensity statin
• CAC ≥1,000: High-intensity statin strongly recommended

Repeat Scanning Intervals

For initial CAC = 0 1:

• Repeat in 5-10 years for low-risk individuals
• Consider repeat in 3-5 years for patients with diabetes or multiple risk factors
• Do not repeat <5 years from initial scan

For CAC >0:

• Limited value in repeat scanning for CAC >400 (already high risk)
• May consider 3-5 year intervals for CAC 1-400 to assess progression

Common Pitfalls to Avoid

1. Ordering CAC in symptomatic patients - these patients need stress testing or coronary CTA, not CAC scoring
2. Using CAC in established CAD - provides no additional management value
3. Ignoring CAC = 0 in high-risk calculators - zero score has powerful negative predictive value and can justify treatment de-escalation
4. Ordering stress testing based solely on high CAC - the 2013 expert consensus does not support routine ischemia testing in asymptomatic patients even with high CAC 2
5. Failing to consider CAC in younger patients with multiple risk factors - traditional risk calculators underestimate risk in this population

Practical Clinical Algorithm

For asymptomatic patients age ≥40:

1. Calculate 10-year ASCVD risk using pooled cohort equations
2. If intermediate (7.5%-20%) or borderline (5%-7.5%) risk → Consider CAC
3. If low risk (<5%) → CAC only if strong family history or multiple risk-enhancing factors
4. If high risk (≥20%) → Initiate statin; CAC generally not needed unless patient refuses treatment
5. Use CAC result to guide statin decision per thresholds above

The fundamental principle: CAC is a tie-breaker when traditional risk assessment leaves treatment decisions uncertain. 2